Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-24-000107

Options or other derivatives

  • Director acquired 217,883 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huber Jeff · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-06-27 Grant or award : show line 1 in the form Stock Option (right to buy) +200,000 200,000 D
2024-06-27 Grant or award : show line 2 in the form Stock Option (right to buy) +17,883 217,883 D
Loading xslF345X05/wk-form4_1719523215.xml…